Credit Suisse’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4
| Closed | – | – | 4281 |
|
|
2022
Q2 | $0 | Sell |
4
-852
| -100% | – | ﹤0.01% | 4306 |
|
|
2022
Q1 | $16K | Buy |
856
+163
| +24% | +$3.05K | ﹤0.01% | 3527 |
|
|
2021
Q4 | $12K | Sell |
693
-7,300
| -91% | -$126K | ﹤0.01% | 3600 |
|
|
2021
Q3 | $296K | Buy |
7,993
+311
| +4% | +$11.5K | ﹤0.01% | 3260 |
|
|
2021
Q2 | $457K | Buy |
7,682
+2,316
| +43% | +$138K | ﹤0.01% | 3074 |
|
|
2021
Q1 | $359K | Sell |
5,366
-1,600
| -23% | -$107K | ﹤0.01% | 3101 |
|
|
2020
Q4 | $421K | Buy |
6,966
+2,432
| +54% | +$147K | ﹤0.01% | 3046 |
|
|
2020
Q3 | $358K | Sell |
4,534
-423
| -9% | -$33.4K | ﹤0.01% | 2826 |
|
|
2020
Q2 | $309K | Buy |
4,957
+2,241
| +83% | +$140K | ﹤0.01% | 2939 |
|
|
2020
Q1 | $145K | Sell |
2,716
-46
| -2% | -$2.46K | ﹤0.01% | 3131 |
|
|
2019
Q4 | $334K | Buy |
2,762
+12
| +0.4% | +$1.45K | ﹤0.01% | 3117 |
|
|
2019
Q3 | $499K | Sell |
2,750
-593
| -18% | -$108K | ﹤0.01% | 2800 |
|
|
2019
Q2 | $435K | Buy |
3,343
+630
| +23% | +$82K | ﹤0.01% | 2859 |
|
|
2019
Q1 | $660K | Buy |
2,713
+91
| +3% | +$22.1K | ﹤0.01% | 2629 |
|
|
2018
Q4 | $500K | Buy |
2,622
+661
| +34% | +$126K | ﹤0.01% | 2741 |
|
|
2018
Q3 | $643K | Sell |
1,961
-831
| -30% | -$272K | ﹤0.01% | 2697 |
|
|
2018
Q2 | $871K | Sell |
2,792
-636
| -19% | -$198K | ﹤0.01% | 2677 |
|
|
2018
Q1 | $835K | Buy |
3,428
+326
| +11% | +$79.4K | ﹤0.01% | 2677 |
|
|
2017
Q4 | $937K | Sell |
3,102
-198
| -6% | -$59.8K | ﹤0.01% | 2580 |
|
|
2017
Q3 | $873K | Buy |
3,300
+1,646
| +100% | +$435K | ﹤0.01% | 2738 |
|
|
2017
Q2 | $436K | Sell |
1,654
-50
| -3% | -$13.2K | ﹤0.01% | 2863 |
|
|
2017
Q1 | $614K | Sell |
1,704
-858
| -33% | -$309K | ﹤0.01% | 2810 |
|
|
2016
Q4 | $739K | Buy |
2,562
+502
| +24% | +$145K | ﹤0.01% | 2897 |
|
|
2016
Q3 | $701K | Sell |
2,060
-286
| -12% | -$97.3K | ﹤0.01% | 2909 |
|
|
2016
Q2 | $997K | Buy |
2,346
+1,083
| +86% | +$460K | ﹤0.01% | 2650 |
|
|
2016
Q1 | $404K | Buy |
1,263
+248
| +24% | +$79.3K | ﹤0.01% | 3070 |
|
|
2015
Q4 | $527K | Sell |
1,015
-103
| -9% | -$53.5K | ﹤0.01% | 3121 |
|
|
2015
Q3 | $328K | Sell |
1,118
-1,706
| -60% | -$501K | ﹤0.01% | 3458 |
|
|
2015
Q2 | $1.11M | Buy |
2,824
+1,653
| +141% | +$650K | ﹤0.01% | 2832 |
|
|
2015
Q1 | $355K | Sell |
1,171
-508
| -30% | -$154K | ﹤0.01% | 3496 |
|
|
2014
Q4 | $374K | Sell |
1,679
-128
| -7% | -$28.5K | ﹤0.01% | 3558 |
|
|
2014
Q3 | $419K | Buy |
1,807
+755
| +72% | +$175K | ﹤0.01% | 3372 |
|
|
2014
Q2 | $233K | Sell |
1,052
-1,364
| -56% | -$302K | ﹤0.01% | 3845 |
|
|
2014
Q1 | $762K | Buy |
2,416
+1,276
| +112% | +$402K | ﹤0.01% | 3010 |
|
|
2013
Q4 | $297K | Buy |
+1,140
| New | +$297K | ﹤0.01% | 3638 |
|
|
2013
Q3 | – | Sell |
-456
| Closed | -$69K | – | 3871 |
|
|
2013
Q2 | $69K | Buy |
+456
| New | +$69K | ﹤0.01% | 3671 |
|